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1. Introduction
Inflammation stands at the centre of a range of natural and
pathological processes, such as ageing, wound healing, infec-
tion, arthritis, autoimmune disease, cardiovascular disease,
cancer, and the inflammatory response to surgery. It is well
accepted that inflammation, in the right place and at the right
time, is at the center of a healthy host response to natural or
man-made stresses. However, systemic or runaway inflam-
mation is pathological and it is incumbent to understand bet-
ter how the inflammatory process is curbed, either naturally
or with intervention.This special issue invited submissions to
expand our understanding of contemporary mechanisms or
approaches to curb the inflammatory response in three broad
settings: (1) the systemic inflammatory response, (2) chronic
inflammation, and (3) natural pathways in inflammatory
resolution. The editors selected a good balance between
original research papers and review articles that addressed
each area of the call.
2. Curbing the Systemic
Inflammatory Response
The systemic inflammatory response was first described in
the critical care field for detecting and managing the whole
body inflammatory reaction in acutely ill patients to sepsis,
burns, or traumatic injuries [1]. It has also been adapted to
recognize the iatrogenic triggering of a systemic inflamma-
tory response in heart surgery due to contact activation of
blood in the extracorporeal bypass circuit [2].
This special issue leads with three reviews discussing
contemporary approaches towards curbing the systemic
inflammatory response in sepsis, burn wounds, and neu-
rogenic inflammation (A. M. Bernard and G. R. Bernard;
J. A. Farina Jr. et al.; K. M. Lewis). Interleukin- (IL-) 6 and
tumor necrosis factor (TNF-) 𝛼 are identified in sepsis and
burns in patients as important mediators at the top of the
inflammatory cascade that may be targeted either through
specific antibody therapy or through the early excision of full
thickness burn tissue that may otherwise act as a cytokine
reservoir. The papers echo the PIRO paradigm put forward
to integrate how predisposing factors (P), the type of Insult
(I) and the host response (R) combine to generate organ
injury (O) [3]. This paradigm has helped shift therapeutic
strategies towards attenuating the PIR steps before Organ
injury (O) occurs. A key transition from PIR to O occurs at
the level of endothelial barrier function that serves to protect
organs from the inflammatory milieu in the circulation [4].
The loss of blood brain barrier (BBB) function is brought
into focus by the paper on neurogenic inflammation, which
discusses substance P as a key mediator of BBB permeability
and, hence, as an attractive therapeutic target for attenuating
injury to the central nervous system following traumatic
brain injury, stroke, and meningitis.
Preexisting factors have also been identified in heart
surgery to explain the differential inflammatory response in
patients towards a common iatrogenic insult [5]. An original
paper in this special issue identified high white cell count
at preadmission as a predictor of surgical complications, as
assessed by frequency of 30-day readmission postsurgery
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(J. R. Brown et al.). White blood cell count is considered a
simple but valid measure of the prevailing inflammatory
status of a patient [6] and, hence, this research again fits the
PIRO model of the systemic inflammatory response.
3. Curbing Chronic Inflammation
This special issue attracted some thought-provoking reviews
on areas of chronic inflammation that have been some-
what overlooked or less popular in the literature. One
review pointed out the surprising decline in interest among
researchers for investigating the role of inflammation after
an acute myocardial infarction (AMI) as opposed to the
causal role prior to an AMI [7] that is well covered in the
literature (P. R. B. Evora et al.). This minority viewpoint,
however, chimes with other advocates who have argued
consistently that certain nagging gaps remain to be explained
in understanding the role of inflammation on AMI outcomes
[8, 9].The review identifies endothelial injury as a gateway in
the pathophysiology of ischemic heart disease and presents
a conceptual overview for curbing this inflammatory disease
process. Transient ischemia is a potential trigger for vascular
permeability changes in endothelium and a submission on
metabolic acidosis addresses this aspect as part of a strategy
to curb inflammation (T. R. de Nadai et al.). Finally, an
original paper compared the immunosuppressive properties
of statins on T-cell immune responses with other conven-
tional immunosuppressive agents, such as cyclosporine or
dexamethasone (A. Jameel et al.). The paper demonstrated
differential immunosuppressive properties of statins on T-
cell proliferation, IL-1𝛽, IL-17, and interferon- (IFN-) 𝛾
production depending on the type of immune activation.
4. Natural Pathways for
Inflammatory Resolution
This special issue concludes with two research papers and a
review addressing the topical issue of proresolving pathways
[10] and how to harness these endogenous pathways to
curb inflammation (B. J. Evans et al.; R. C. Landis et al.;
T. J. Ahmed et al.). Two papers describe the evolution of
the “wound healing” macrophage [11, 12], defined by the
expression of CD163 (hemoglobin scavenging receptor), uti-
lizing in vitro and in vivo approaches. CD163+ macrophages
are shown to promote anti-inflammatory and cytoprotec-
tive pathways in vitro to limit prooxidant injury due to
free heme, via pathways involving phosphatidylinositol-3-
kinase activation, Akt phosphorylation, and IL-10 secre-
tion. CD163+ cells were associated in the second paper
with the phagocytic removal of apoptotic neutrophils,
hence limiting potential histotoxic injury, with a shifting
of the cytokine profile from proinflammatory mediators,
including TNF-𝛼, IL-6, IL-8/CXCL8, monocyte chemoat-
tractant protein (MCP-1/CCL2), macrophage inflamma-
tory protein (MIP1𝛼/CCL3), MIP-1𝛽/CCL4, and eotaxin
(CCL11), towards immunoregulatory mediators, including
macrophage-derived chemokine (MDC/CCL22), interferon-
inducible protein (IP-10/CXCL10), and transforming growth
factor (TGF)-𝛽. Finally, an interesting review of proresolving
mediators highlights the promise ofmelanocortin peptides as
agents to limit the inflammatory process and protect tissues
in a variety of preclinical models for inflammatory disease.
5. Conclusion
The editors are pleased to present this special issue on curb-
ing inflammation and trust it will be popular with a wide
readership, from basic scientists, critical care physicians,
surgeons, rheumatologists, cardiovascular researchers, and
many more, since the inflammatory response impacts on
so many fields and disease processes. The editors hope
that this special issue will provide a conceptual framework
and stimulate new ideas in the development of therapeutic
strategies to curb the pathological inflammatory response.
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